Article ID Journal Published Year Pages File Type
8817603 Biomedical and Environmental Sciences 2017 8 Pages PDF
Abstract
Baseline HBsAg levels and extended therapy are critical steps toward HBsAg loss. Baseline HBsAg levels together with early response determined the treatment time of HBsAg loss in patients with HBeAg-positive chronic hepatitis B during pegylated interferon alpha-2a treatment.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Public Health and Health Policy
Preview
The Predictive Value of Baseline HBsAg Level and Early Response for HBsAg Loss in Patients with HBeAg-positive Chronic Hepatitis B during Pegylated Interferon Alpha-2a Treatment
Authors
, , , , , , , , , , , , , ,